STERIS plc (NYSE:STE) Shares Purchased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board grew its position in shares of STERIS plc (NYSE:STE - Free Report) by 219.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,888 shares of the medical equipment provider's stock after purchasing an additional 4,735 shares during the period. Canada Pension Plan Investment Board's holdings in STERIS were worth $1,416,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in STE. Avalon Trust Co acquired a new stake in STERIS during the 4th quarter valued at $30,000. Human Investing LLC acquired a new stake in shares of STERIS during the fourth quarter valued at about $31,000. Anfield Capital Management LLC increased its position in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC lifted its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 137 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Performance

Shares of NYSE STE traded down $1.35 during midday trading on Friday, hitting $225.00. The company's stock had a trading volume of 368,819 shares, compared to its average volume of 526,071. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 1-year low of $200.98 and a 1-year high of $248.24. The firm's fifty day moving average price is $222.89 and its 200-day moving average price is $218.90. The firm has a market cap of $22.11 billion, a P/E ratio of 47.77 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is 48.41%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on STE. Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities reissued a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Piper Sandler upped their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Finally, Stephens reissued an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.